2025-02-10

Fallon Williams and her daughter have similar heart conditions, which do not have a known genetic cause. Williams hopes whole genome sequencing can provide answers and improve cardiac care for all.

2025-02-06

February is National Cancer Prevention Month. ARUP Consult provides guidance on hereditary cancer germline genetic testing for early detection and management of inherited cancer syndromes.

2025-02-03

The partnership combines Tasso’s clinical grade blood collection solutions and ARUP’s gold standard testing capabilities to streamline and accelerate decentralized clinical research.

2025-01-13

ARUP Consult offers expert guidance on laboratory testing for influenza, RSV, and COVID-19, helping clinicians order the right tests at the right time.

2025-01-08

ARUP Healthcare Advisory Services can help labs prepare for the quality management system requirements in the FDA’s final rule on laboratory-developed tests, despite the rule’s uncertain future.

2025-01-06

ARUP supported 15 families resettling in Utah through the International Rescue Committee’s Light One Candle initiative with donations that included toys, toiletries, and TVs.

2025-01-03

ARUP has launched a new assay for the detection and subtyping of influenza A (H5) virus, which will expand the national capacity to detect the current outbreak of highly pathogenic avian influenza A (H5N1).

2024-12-20

Benjamin Bradley, MD, PhD, compared the H5N1 outbreak to COVID-19, highlighting the preparedness of labs and the CDC’s proactive approach during a media briefing.

2024-12-06

Next generation sequencing (NGS) testing detects UBA1 gene mutations, which are essential for the diagnosis of VEXAS syndrome and concurrent hematologic neoplasms.

2024-11-19

This edition features interviews with company leaders describing ARUP’s approaches to comply with the FDA’s rule and a video about how ARUP helped a family on a rare disease diagnostic journey.

Subscribe to Corporate News